Gallardo, A., Lerma, E., Escuin, D., Tibau, A., Muñoz, J., Ojeda, B., . . . Peiró, G. (2012). Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Nature Publishing Group.
Chicago Style aipamenaGallardo, A., et al. Increased Signalling of EGFR and IGF1R, and Deregulation of PTEN/PI3K/Akt Pathway Are Related With Trastuzumab Resistance in HER2 Breast Carcinomas. Nature Publishing Group, 2012.
MLA aipamenaGallardo, A., et al. Increased Signalling of EGFR and IGF1R, and Deregulation of PTEN/PI3K/Akt Pathway Are Related With Trastuzumab Resistance in HER2 Breast Carcinomas. Nature Publishing Group, 2012.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.